Notable Stocks: American International Group (NYSE:AIG), ADT Corp (NYSE:ADT), Ion Geophysical (NYSE:IO), Celldex Therapeutics, Inc. (NASDAQ:CLDX)

American International Group, Inc. (NYSE:AIG) announced that it will redeem all of its outstanding 3.000% Notes Due 2015 (CUSIP No. 026874CT2) (the “Notes”) on May 5, 2014 (the “Redemption Date”). American International Group Inc (NYSE:AIG) shares after opening at $51.25 moved to $51.82 on last trade day and at the end of the day closed at $50.55. Company price to sales ratio in past twelve months was calculated as 1.06 and price to cash ratio as 32.69. American International Group Inc (NYSE:AIG) showed a positive weekly performance of 1.34%.

ADT Corp (NYSE:ADT) was the target of some unusual options trading activity on Thursday. Traders purchased 13,338 call options on the stock, AnalystRatings.NET reports. This represents an increase of 498% compared to the average daily volume of 2,229 call options. ADT Corp (NYSE:ADT) shares advanced 0.37% in last trading session and ended the day on $32.18. ADT return on equity ratio is recorded as 9.40% and its return on assets is 4.00%. ADT Corp (NYSE:ADT) yearly performance is -29.75%.

ION Geophysical Corporation (NYSE:IO) is collaborating with Polarcus to acquire a new 4,000-sq km (1,544-sq mi) 3D multi-client seismic survey in the deepwater Southern Porcupine basin offshore southwest Ireland. Ion Geophysical Corp (NYSE:IO) shares moved down -1.68% in last trading session and was closed at $4.10 while trading in range of $4.02 – $4.25 – Ion Geophysical Corp (NYSE:IO) year to date (YTD) performance is 24.24%.

elldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2013 and outlined the Company’s major clinical development goals for 2014. Celldex Therapeutics, Inc. (NASDAQ:CLDX) weekly performance is -5.78%. On last trading day company shares ended up $15.97. Celldex Therapeutics, Inc. (NASDAQ:CLDX) distance from 50-day simple moving average (SMA50) is -36.01%. Analysts mean target price for the company is $36.33.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *